Your browser doesn't support javascript.
loading
S-1 plus leucovorin and oxaliplatin versus S-1 plus cisplatin as first-line therapy in patients with advanced gastric cancer (SOLAR): a randomised, open-label, phase 3 trial.
Kang, Yoon-Koo; Chin, Keisho; Chung, Hyun Cheol; Kadowaki, Shigenori; Oh, Sang Cheul; Nakayama, Norisuke; Lee, Keun-Wook; Hara, Hiroki; Chung, Ik-Joo; Tsuda, Masahiro; Park, Se Hoon; Hosaka, Hisashi; Hironaka, Shuichi; Miyata, Yoshinori; Ryu, Min-Hee; Baba, Hideo; Hyodo, Ichinosuke; Bang, Yung-Jue; Boku, Narikazu.
Afiliação
  • Kang YK; Department of Oncology, Asan Medical Centre, University of Ulsan College of Medicine, Seoul, South Korea.
  • Chin K; Department of Gastroenterology, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Chung HC; Division of Medical Oncology, Institute for Cancer Research, Yonsei University College of Medicine, Yonsei University Health System, Seoul, South Korea.
  • Kadowaki S; Department of Clinical Oncology, Aichi Cancer Centre Hospital, Aichi, Japan.
  • Oh SC; Department of Oncology, Korea University Guro Hospital, Korea University College of Medicine, Seoul, South Korea.
  • Nakayama N; Department of Gastroenterology, Kanagawa Cancer Centre, Kanagawa, Japan.
  • Lee KW; Division of Haematology and Medical Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea.
  • Hara H; Department of Gastroenterology, Saitama Cancer Centre, Saitama, Japan.
  • Chung IJ; Department of Haematology-Oncology, Chonnam National University Hwasun Hospital, Chonnam National University College of Medicine, Hwasun, South Korea.
  • Tsuda M; Department of Gastroenterological Oncology, Hyogo Cancer Centre, Hyogo, Japan.
  • Park SH; Department of Medicine, Division of Haematology-Oncology, Samsung Medical Centre, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Hosaka H; Department of Gastroenterology, Gunma Prefectural Cancer Centre, Gunma, Japan.
  • Hironaka S; Clinical Trial Promotion Department, Chiba Cancer Centre, Chiba, Japan.
  • Miyata Y; Department of Medical Oncology, Saku Central Hospital Advanced Care Centre, Nagano, Japan.
  • Ryu MH; Department of Oncology, Asan Medical Centre, University of Ulsan College of Medicine, Seoul, South Korea.
  • Baba H; Department of Gastroenterological Surgery, Kumamoto University, Kumamoto, Japan.
  • Hyodo I; Department of Gastroenterology, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan.
  • Bang YJ; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea.
  • Boku N; Division of Gastrointestinal Medical Oncology, National Cancer Centre Hospital, Tokyo, Japan. Electronic address: nboku@ncc.go.jp.
Lancet Oncol ; 21(8): 1045-1056, 2020 08.
Article em En | MEDLINE | ID: mdl-32682457
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Clinical_trials / Guideline Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Coréia do Sul
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Clinical_trials / Guideline Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Coréia do Sul